Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Mol Imaging Biol. 2009 Mar 27;11(5):303–307. doi: 10.1007/s11307-009-0209-0

Fig 2.

Fig 2

The posterior and right lateral projections of fused SPECT/CT acquisitions at two time points in tumored mice pretargeted with MORF-CC49 and injected with 99mTc-cMORF (top panels) or 111In-cMORF (bottom panels). Bladder 99mTc and 111In radioactivity have been digitally removed in all projections.